The Cooper Companies, Inc. COO

55.38 0.00 0.00% as of 25 Sep
Market cap
$10.5B
P/E
18.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

The Cooper Companies, Inc. (COO) Revenue growth

The Cooper Companies, Inc.'s revenue growth over the twelve months to 31 July 2026 was 4.73%, down 0.3 percentage points from fiscal 2025 (5.06%). Over the past ten years it has ranged from −8.39% (fiscal 2020) to 20.2% (fiscal 2021); the current reading is higher than 36% of that period. That is below the Medical Instruments & Supplies industry median of 9.20% and below the Healthcare sector median of 8.26%.

Revenue growth, annual

Annual

Period Revenue growth Change (points)
FY2025 5.06% (3.35)
FY2024 8.41% (0.20)
FY2023 8.61% (4.59)
FY2022 13.2% (7.02)
FY2021 20.2% 28.61
FY2020 −8.39% (13.15)
FY2019 4.76% (13.65)
FY2018 18.4% 9.65
FY2017 8.76% (0.68)
FY2016 9.44% 4.82

Quarterly

Period Revenue growth Change (points)
Jul 2026 0.56% (7.34)
Apr 2026 7.90% 1.74
Jan 2026 6.16% 1.57
Oct 2025 4.59% (1.14)
43 more quarters

Against its own ten years

Low −8.39% High 20.2%
Ten-year median 8.61%
Current reading's percentile 36

Revenue growth against peers

Company Revenue growth
RGEN Repligen Corporation compare 16.5%
STVN Stevanato Group S.p.A. compare 14.3%
ATR AptarGroup, Inc. compare 8.93%
BLCO Bausch + Lomb Corporation compare 8.85%
BAX Baxter International Inc. compare 5.36%
COO The Cooper Companies, Inc. 4.73%
ALGN Align Technology, Inc. compare 4.41%
SOLV Solventum Corporation compare −0.93%
AVTR Avantor, Inc. compare −1.57%
Medical Instruments & Supplies industry median 9.20%
Healthcare sector median 8.26%
Market median 7.41%

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on COO